NCT02929771 is a NA clinical trial of Samsung GearVR in Cancer, sponsored by The Hospital for Sick Children.

Who is sponsoring NCT02929771?

NCT02929771 is sponsored by The Hospital for Sick Children.

What drugs are being tested in NCT02929771?

Interventions in NCT02929771: Samsung GearVR, iPad.

Is NCT02929771 still recruiting?

NCT02929771 is currently completed. Last updated 20 April 2020.

Last reviewed 2020-04-20 · How we verify

NCT02929771

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Virtual Reality to Reduce Procedural Pain in Children With Cancer

Completed NA Last updated 20 April 2020

What this trial tests

NA trial testing Samsung GearVR in Cancer in 40 participants. Completed in 31 December 2019.

Timeline

1 August 2017

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	The Hospital for Sick Children
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	1 August 2017
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across Canada

Drugs / interventions tested

Samsung GearVR
iPad

Conditions studied

Cancer — all drugs for Cancer →

Sponsor

The Hospital for Sick Children

Who can join

Adults 8 to 18, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess the impact of virtual reality (VR) in decreasing procedural pain related to subcutaneous port (SCP) access in children with cancer. The study is a pilot-randomized controlled trial (RCT) using a cross-over design that will provide us with detailed information on the feasibility of implementing our trial protocol in a future multi-center RCT as well as preliminary estimate of VR treatment effect on children with cancer undergoing SCP access, including child and parent factors potentially associated with VR distraction treatment efficacy.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Virtual reality distraction for acute pain in children.
Lambert V, Boylan P, Boran L, Hicks P, et al · · 2020 · cited 50× · PMID 33089901 · DOI 10.1002/14651858.cd010686.pub2
A Pilot Randomized Controlled Trial of Virtual Reality Distraction to Reduce Procedural Pain During Subcutaneous Port Access in Children and Adolescents With Cancer.
Hundert AS, Birnie KA, Abla O, Positano K, et al · · 2021 · cited 47× · PMID 34974512 · DOI 10.1097/ajp.0000000000001017

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other The Hospital for Sick Children trials

Trials by the same sponsor.

NCT07454681 — MRI Assessment of Lung Airways in Cystic Fibrosis: Evaluate MRI's Ability to Detect Changes in Airway Structure . · not yet recruiting
NCT07452575 — 3D Ultrasound in Hemophilic Ankles · NA · not yet recruiting
NCT07508826 — AI-assisted Endotracheal Intubation · NA · not yet recruiting
NCT07345819 — Dexamethasone vs. Placebo in Children and Youth Hospitalized for Orbital Cellulitis · NA · not yet recruiting
NCT07497178 — MRgFUS for Childhood Epilepsy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02929771 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Hospital for Sick Children
Last refreshed: 20 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02929771.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing